Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples
- PMID: 30376092
- PMCID: PMC6206103
- DOI: 10.1093/cid/ciy648
Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples
Abstract
Background: Global polio eradication efforts rely in part on molecular methods of detecting polioviruses, both wild and vaccine strains, from human and environmental samples. Previous assays used for detection of Sabin oral polio vaccine (OPV) in fecal samples have been labor and time intensive and vary in their sensitivity and specificity.
Methods: We developed a high-throughput, multiplex reverse-transcription quantitative polymerase chain reaction assay able to detect all 3 OPV strains in fecal samples. The assay used a KingFisher Duo Prime system for viral RNA isolation and extraction. Positive samples were retested and Sanger sequenced for verification of Sabin serotype identity.
Results: The 95% lower limit of detection was determined to be 3 copies per reaction for Sabin 1 and 3 and 4 copies per reaction for Sabin 2, with no cross-reactivity between the 3 serotypes and their primers. A total of 554 samples (3.6%) were positive, with 304 positive samples (54.9%) containing >1 serotype. Of the positive samples, 476 (85.9%) contained enough RNA to be sequenced, and of these all sequences were Sabin serotypes. The previous assay we used could process 48 samples in a 10-hour period, whereas the new assay processed >100 samples in 6 hours.
Conclusions: The new high-throughput, multiplex reverse-transcription quantitative polymerase chain reaction assay allowed for sensitive and specific detection of OPV serotypes while greatly decreasing sample handling and processing time. We were able to sequence 72.4% of the 210 positive samples in the cycle threshold range of 35-37.
Similar articles
-
Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.Clin Infect Dis. 2018 Oct 30;67(suppl_1):S98-S102. doi: 10.1093/cid/ciy639. Clin Infect Dis. 2018. PMID: 30376093 Free PMC article.
-
Multiplex PCR-based titration (MPBT) assay for determination of infectious titers of the three Sabin strains of live poliovirus vaccine.Virol J. 2019 Oct 28;16(1):122. doi: 10.1186/s12985-019-1233-6. Virol J. 2019. PMID: 31660997 Free PMC article.
-
Development of a multiplex RT-PCR assay for the identification of recombination types at different genomic regions of vaccine-derived polioviruses.Virus Genes. 2016 Aug;52(4):453-62. doi: 10.1007/s11262-016-1333-y. Epub 2016 Apr 20. Virus Genes. 2016. PMID: 27098645
-
Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.Expert Rev Vaccines. 2012 May;11(5):609-28. doi: 10.1586/erv.12.28. Expert Rev Vaccines. 2012. PMID: 22827246 Review.
-
Circulating vaccine-derived polioviruses: current state of knowledge.Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26. Bull World Health Organ. 2004. PMID: 15106296 Free PMC article. Review.
Cited by
-
Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.Clin Infect Dis. 2018 Oct 30;67(suppl_1):S98-S102. doi: 10.1093/cid/ciy639. Clin Infect Dis. 2018. PMID: 30376093 Free PMC article.
-
Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings.Clin Infect Dis. 2018 Oct 30;67(suppl_1):S26-S34. doi: 10.1093/cid/ciy605. Clin Infect Dis. 2018. PMID: 30376087 Free PMC article.
-
OPV Vaccination and Shedding Patterns in Mexican and US Children.Clin Infect Dis. 2018 Oct 30;67(suppl_1):S85-S89. doi: 10.1093/cid/ciy636. Clin Infect Dis. 2018. PMID: 30376085 Free PMC article.
References
-
- Minor PD. An introduction to poliovirus: pathogenesis, vaccination, and the endgame for global eradication. Methods Mol Biol 2016; 1387:1–10. - PubMed
-
- Nkowane BM, Wassilak SGF, Orenstein WA, et al. . Vaccine-associated paralytic poliomyelitis United States: 1973 through 1984. JAMA 1987; 257:1335–40. - PubMed
-
- Global Polio Eradication Initiative. Reporting and classification of vaccine-derived polioviruses: GPEI guidelines. Geneva, Switzerland: Global Eradication Initiative, 2015.
-
- Majid L, Kathleen L, Robert B, et al. . Analysis of reversions in the 5′-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines. J Infect Dis 2006; 193:1344–49. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous